Pharmaceutical Technology
NOVEMBER 30, 2022
in a project agreement from the US government for developing self-amplifying RNA (saRNA) vaccine technology against advanced and emergent viral threats. Development of vaccines to Phase I trials under the five-year $59m prototype project comprises additional $28.4m in milestone payments.
Drug Discovery World
JANUARY 24, 2023
Virtual clinical trials ‘Virtual’ and ‘technology’ are concepts which are readily exchanged in this industry, but these are more than just buzzwords. The overall virtual clinical trials market is currently valued at $7.8 However, it also made great strides in proving the success of these sorts of trials.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
DECEMBER 23, 2020
Additionally, Phase 1 clinical data found INO-4800 to have a favorable safety and tolerability profile with no serious adverse events reported; only six Grade 1 adverse events (AEs) were observed, primarily minor injection site reactions. ” Findings from the Phase 1 Clinical Trial. mg and 2.0
Delveinsight
DECEMBER 10, 2020
AstraZeneca’s COVID-19 vaccine data suggest single-dose efficacy. The full data from late-phase trials of AstraZeneca’s COVID-19 vaccine have pointed to the potential for AZD1222 to work after a single dose and limit asymptomatic cases; however, missed main questions regarding the efficacy of the candidate.
Bioengineer
JULY 15, 2021
“In clinical trials, we tend to go with the maximum tolerable dose, the idea being that radiation kills the cancer and the more we give, the better. professor of radiology at the University of Wisconsin School of Medicine and Public Health, in collaboration with co-author Reinier Hernandez, Ph.D., ” ###.
The Pharma Data
NOVEMBER 18, 2020
The California company said that clinical trials showed 100% of patients were able to perform the Lucira test in about two minutes. ” COVID Vaccines Move Closer to Emergency Use Approval. The vaccine’s efficacy was consistent across age, race and ethnicity, the companies said. Meanwhile, Moderna Inc.
The Pharma Data
APRIL 17, 2021
New findings on the use of VUMERITY in a real-world setting reinforce the benefits of improved gastrointestinal (GI) tolerability and confirm that the experience in clinical trials is consistent with clinical practice. Of these, 6,335 patients (14,241 patient-years) were from clinical trials.
Expert insights. Personalized for you.
147 
Let's personalize your content